التفاصيل البيبلوغرافية
| العنوان: |
Treatment strategies for insomnia in Japanese primary care physicians' practice: A Web-based questionnaire survey. |
| المؤلفون: |
Takeshima, Masahiro, Sakurai, Hitoshi, Inada, Ken, Aoki, Yumi, Ie, Kenya, Kise, Morito, Yoshida, Eriko, Matsui, Kentaro, Utsumi, Tomohiro, Shimura, Akiyoshi, Okajima, Isa, Kotorii, Nozomu, Yamashita, Hidehisa, Suzuki, Masahiro, Kuriyama, Kenichi, Shimizu, Eiji, Mishima, Kazuo, Watanabe, Koichiro, Takaesu, Yoshikazu |
| المصدر: |
BMC Primary Care; 6/18/2024, Vol. 25 Issue 1, p1-10, 10p |
| مصطلحات موضوعية: |
INSOMNIA treatment, BENZODIAZEPINES, PSYCHOTHERAPY, SCALE analysis (Psychology), CROSS-sectional method, CHINESE medicine, FAMILY medicine, SEDATIVES, RESEARCH funding, DRUG therapy, QUESTIONNAIRES, TRANQUILIZING drugs, DESCRIPTIVE statistics, PROFESSIONS, PHYSICIAN practice patterns, GENERIC drug substitution, COGNITIVE therapy, COMPARATIVE studies, DATA analysis software, CONFIDENCE intervals, TRAZODONE, DRUG utilization, RELAXATION techniques, QUETIAPINE, SLEEP hygiene |
| مصطلحات جغرافية: |
JAPAN |
| مستخلص: |
Background: It is unclear how primary care physicians manage insomnia after the introduction of novel hypnotics such as orexin receptor antagonists and melatonin receptor agonists. This Web-based questionnaire survey aimed to examine treatment strategies for insomnia in Japanese primary care practice. Methods: One-hundred-and-seventeen primary care physicians were surveyed on the familiarity of each management option for insomnia on a binary response scale (0 = "unfamiliar"; 1 = "familiar") and how they managed insomnia using a nine-point Likert scale (1 = "I never prescribe/perform it"; 9 = "I often prescribe/perform it"). Physicians who were unfamiliar with a management option were deemed to have never prescribed or performed it. Results: Regarding medication, most physicians were familiar with novel hypnotics. Suvorexant was the most used hypnotic, followed by lemborexant and ramelteon. These novel hypnotics averaged 4.8–5.4 points and 4.0–4.7 points for sleep onset and sleep maintenance insomnia, respectively. By contrast, most benzodiazepines were seldom used below two points. Regarding psychotherapy, only approximately 40% of the physicians were familiar with cognitive behavioral therapy for insomnia (CBT-I) and they rarely implemented it, at an average of 1.5–1.6 points. More physicians were familiar with single-component psychotherapies (i.e., relaxation, sleep restriction therapy, and stimulus control) compared to CBT-I, and 48–74% of them implemented it slightly more often, with scores ranging from 2.6 to 3.4 points. Conclusion: This study suggests that Japanese primary care physicians seldom use CBT-I to treat insomnia. In addition, they use novel sleep medications more frequently than benzodiazepines in terms of pharmacotherapy. The use and availability of CBT-I in Japanese primary care might be facilitated by: educating primary care physicians, implementing brief or digital CBT-I, and/or developing collaborations between primary care physicians and CBT-I specialists. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Primary Care is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Find this article in full text from Springer Verlag. 
Full Text Finder